诊断标准:评估肾小球滤过率
基于肌酐的eGFR在个体层面不精确,受非GFR相关因素如非典型肌肉量影响;胱抑素C不依赖肌肉量,但仅当与肌酐联合纳入方程时才优于肌酐方程。新的无种族CKD-EPI方程在美国黑人与非黑人间有轻微相反偏倚,在欧洲人群表现差于旧版;2021年EKFC方程适用于儿童和成人,对年轻和老年成人更准确,并可通过调整Q因子适用于非白人欧洲人群。
要点
- 基于肌酐的eGFR在个体层面不精确,受非GFR相关因素如非典型肌肉量影响。
- 胱抑素C不依赖肌肉量,但胱抑素C方程仅在联合肌酐时才优于肌酐方程。
- 2021年EKFC方程适用于儿童和成人,对年轻和老年成人更准确,可调整Q因子适用于非白人欧洲人群。
核心结论
- 基于肌酐的eGFR在个体层面不精确,受非GFR相关因素影响;胱抑素C方程仅在联合肌酐时优于肌酐方程;EKFC方程在儿童和成人中更准确,并可通过调整Q因子适用非白人欧洲人群。
研究设计与样本
- 综述类:检索范围原文未明确报告。
主要发现
- 基于肌酐的eGFR在个体层面不精确,受非GFR相关血清肌酐决定因素包括非典型肌肉量影响。
- 胱抑素C不依赖肌肉量,但胱抑素C方程除非与肌酐同时纳入,否则估算GFR并不优于肌酐方程。
- 新的无种族CKD-EPI方程在美国黑人与非黑人受试者间有轻微相反偏倚,在欧洲人群表现差于旧版。
- 2021年EKFC方程可用于儿童和成人,对年轻和老年成人更准确,并通过调整Q因子适用于非白人欧洲人群。
- 已定义性别和种族无关的胱抑素C-based EKFC方程,采用相同数学设计。
关键数值与推荐
- 无种族CKD-EPI方程在美国黑人与非黑人受试者间有轻微相反偏倚,在欧洲人群表现差于旧版。
- 2021年EKFC方程可用于儿童和成人,对年轻和老年成人更准确,通过调整Q因子(人群肌酐中位数)以潜在通用方式适用于非白人欧洲人群。
- 已定义性别和种族无关的胱抑素C-based EKFC方程,采用相同数学设计。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Creatinine-based estimated glomerular filtration rate (eGFR) is imprecise at individual level, due to non-GFR-related serum creatinine determinants, including atypical muscle mass. Cystatin C has the advantage of being independent of muscle mass, a feature that led to the development of race- and sex-free equations. Yet, cystatin C-based equations do not perform better than creatinine-based equations for estimating GFR unless both variables are included together. The new race-free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation had slight opposite biases between Black and non-Black subjects in the USA, but has poorer performance than that the previous version in European populations. The European Kidney Function Consortium (EKFC) equation developed in 2021 can be used in both children and adults, is more accurate in young and old adults, and is applicable to non-white European populations, by rescaling the Q factor, i.e. population median creatinine, in a potentially universal way. A sex- and race-free cystatin C-based EKFC, with the same mathematical design, has also be defined. New developments in the field of GFR estimation would be standardization of cystatin C assays, development of creatinine-based eGFR equations that incorporate muscle mass data, implementation of new endogenous biomarkers and the use of artificial intelligence. Standardization of different GFR measurement methods would also be a future challenge, as well as new technologies for measuring GFR. Future research is also needed into discrepancies between cystatin C and creatinine, which is associated with high risk of adverse events: we need to standardize the definition of discrepancy and understand its determinants.
引用
- Delanaye P, Pottel H, Cavalier E, et al. Diagnostic standard: assessing glomerular filtration rate. Nephrol Dial Transplant. 2024. PMID: 37950562. doi:10.1093/ndt/gfad241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。